Hutch Lands $4.3M for Transplant PGx | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Fred Hutchinson Cancer Research Center plans to use a $4.3 million grant from the National Heart, Blood, and Lung Institute to study whether or not genetic variations could be used to predict patient outcomes and complications of patients undergoing stem-cell transplantation to treat blood cancers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.